Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD8-positive, alpha-beta T cell | 8 studies | 24% ± 8% | |
gamma-delta T cell | 4 studies | 27% ± 8% | |
natural killer cell | 4 studies | 24% ± 6% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 35% ± 7% | |
mature NK T cell | 3 studies | 34% ± 17% | |
effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of ZNF683 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 82% | 95.50 | 476 / 578 | 75% | 4.37 | 866 / 1155 |
thymus | 81% | 76.27 | 532 / 653 | 75% | 6.00 | 454 / 605 |
prostate | 76% | 64.73 | 185 / 245 | 60% | 1.54 | 303 / 502 |
stomach | 64% | 51.08 | 228 / 359 | 53% | 4.04 | 153 / 286 |
breast | 41% | 28.51 | 189 / 459 | 74% | 4.22 | 824 / 1118 |
kidney | 47% | 22.24 | 42 / 89 | 63% | 2.49 | 570 / 901 |
uterus | 29% | 12.41 | 49 / 170 | 71% | 8.19 | 324 / 459 |
bladder | 52% | 33.38 | 11 / 21 | 46% | 3.10 | 231 / 504 |
pancreas | 36% | 11.55 | 118 / 328 | 54% | 1.89 | 96 / 178 |
tonsil | 0% | 0 | 0 / 0 | 87% | 8.55 | 39 / 45 |
ovary | 20% | 5.83 | 36 / 180 | 64% | 3.23 | 277 / 430 |
spleen | 84% | 60.29 | 202 / 241 | 0% | 0 | 0 / 0 |
esophagus | 40% | 15.36 | 579 / 1445 | 37% | 1.56 | 67 / 183 |
skin | 29% | 9.88 | 518 / 1809 | 46% | 2.04 | 215 / 472 |
peripheral blood | 69% | 297.19 | 642 / 929 | 0% | 0 | 0 / 0 |
intestine | 29% | 10.93 | 281 / 966 | 39% | 2.03 | 208 / 527 |
liver | 31% | 9.51 | 70 / 226 | 29% | 0.86 | 116 / 406 |
adipose | 40% | 13.86 | 482 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 0.89 | 11 / 29 |
brain | 20% | 8.65 | 539 / 2642 | 8% | 0.14 | 54 / 705 |
adrenal gland | 12% | 3.26 | 32 / 258 | 15% | 0.36 | 35 / 230 |
blood vessel | 24% | 8.67 | 324 / 1335 | 0% | 0 | 0 / 0 |
heart | 13% | 3.31 | 115 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.35 | 7 / 80 |
muscle | 5% | 1.79 | 43 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0010468 | Biological process | regulation of gene expression |
GO_0051136 | Biological process | regulation of NK T cell differentiation |
GO_0033082 | Biological process | regulation of extrathymic T cell differentiation |
GO_0032823 | Biological process | regulation of natural killer cell differentiation |
GO_0032826 | Biological process | regulation of natural killer cell differentiation involved in immune response |
GO_0045087 | Biological process | innate immune response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF683 |
Protein name | Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell) (Hobit) (Zinc finger protein 683) Zinc finger protein 683 |
Synonyms | |
Description | FUNCTION: Transcription factor that mediates a transcriptional program in various innate and adaptive immune tissue-resident lymphocyte T-cell types such as tissue-resident memory T (Trm), natural killer (trNK) and natural killer T (NKT) cells and negatively regulates gene expression of proteins that promote the egress of tissue-resident T-cell populations from non-lymphoid organs. Plays a role in the development, retention and long-term establishment of adaptive and innate tissue-resident lymphocyte T cell types in non-lymphoid organs, such as the skin and gut, but also in other nonbarrier tissues like liver and kidney, and therefore may provide immediate immunological protection against reactivating infections or viral reinfection. Also plays a role in the differentiation of both thymic and peripheral NKT cells. Negatively regulates the accumulation of interferon-gamma (IFN-gamma) in NKT cells at steady state or after antigenic stimulation. Positively regulates granzyme B production in NKT cells after innate stimulation. Associates with the transcriptional repressor PRDM1/BLIMP1 to chromatin at gene promoter regions. .; FUNCTION: [Isoform 1]: Lacks transcriptional repressor activity. Binds to DNA within promoter regions of the transcriptional repressor PRDM1/BLIMP1 target sites. Unable to regulate interferon-gamma (IFN-gamma) production in cytomegalovirus (CMV)-infected effector CD8(+) T-cells. .; FUNCTION: [Isoform 2]: Transcriptional repressor that binds to DNA within promoter regions of the transcriptional repressor PRDM1/BLIMP1 target sites. Regulates interferon-gamma (IFN-gamma) production in cytomegalovirus (CMV)-infected effector CD8(+) T cells. . |
Accessions | Q5T145 ENST00000451801.5 A0A0A0MT21 X1WI31 ENST00000455900.5 ENST00000403843.5 [Q8IZ20-1] ENST00000436292.5 [Q8IZ20-1] ENST00000349618.8 [Q8IZ20-2] Q5T142 ENST00000416125.1 ENST00000454975.1 ENST00000453132.5 X1WI32 A0A0A0MSJ7 ENST00000423508.5 Q8IZ20 |